Patient-specific iPSC-derived cellular models of LGMDR1
Limb-girdle muscular dystrophy recessive 1 (LGMDR1) represents one of the most common types of LGMD in the population, where patients develop a progressive muscle degeneration. The disease is caused by mutations in calpain 3 gene, with over 500 mutations reported to date. However, the molecular even...
Main Authors: | A.J. Mateos-Aierdi, M. Dehesa-Etxebeste, M. Goicoechea, A. Aiastui, Y. Richaud-Patin, S. Jiménez-Delgado, A. Raya, N. Naldaiz-Gastesi, A. López de Munain |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Stem Cell Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506121001793 |
Similar Items
-
Current and Future Therapeutic Strategies for Limb Girdle Muscular Dystrophy Type R1: Clinical and Experimental Approaches
by: İzem Olcay Şahin, et al.
Published: (2021-05-01) -
Allosteric Modulation of GSK-3β as a New Therapeutic Approach in Limb Girdle Muscular Dystrophy R1 Calpain 3-Related
by: Anabel Rico, et al.
Published: (2021-07-01) -
Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with <i>CAPN3</i> Mutations
by: Jaione Lasa-Elgarresta, et al.
Published: (2019-09-01) -
Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency
by: Julio Castaño, et al.
Published: (2021-08-01) -
Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
by: Elena Abati, et al.
Published: (2021-09-01)